Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Capital Expenditures (2016 - 2025)

Ultralife (ULBI) has 15 years of Capital Expenditures data on record, last reported at $995000.0 in Q3 2025.

  • For Q3 2025, Capital Expenditures rose 67.51% year-over-year to $995000.0; the TTM value through Sep 2025 reached $1.9 million, up 1417.46%, while the annual FY2024 figure was $248000.0, 28.53% down from the prior year.
  • Capital Expenditures reached $995000.0 in Q3 2025 per ULBI's latest filing, down from $1.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.1 million in Q2 2025 and bottomed at -$1.2 million in Q4 2023.
  • Average Capital Expenditures over 4 years is $339500.0, with a median of $506500.0 recorded in 2023.
  • Peak YoY movement for Capital Expenditures: crashed 30.23% in 2024, then soared 205.56% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at $489000.0 in 2021, then crashed by 345.4% to -$1.2 million in 2023, then rose by 10.17% to -$1.1 million in 2024, then surged by 192.3% to $995000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $995000.0 in Q3 2025, $1.1 million in Q2 2025, and $895000.0 in Q1 2025.